How much funding has AORTYX raised?

AORTYX has raised $16.0M in total funding, most recently a Series A round.

Who are AORTYX's investors?

AORTYX's investors include Ship2B, Clave Capital, European Innovation Council Fund.

Where is AORTYX headquartered?

AORTYX is headquartered in Barcelona.

What industry is AORTYX in?

AORTYX operates in Biotech, Medical Devices.

AORTYX

The ultimate solution for aortic diseases

Barcelona · Founded 2018 · $16.0M raised

Biotech

Medical Devices

Headquarters: Barcelona
Employees: 11–50
Founded: 2018
Business Model: B2B

Website: aortyx.com
Total Funding: $16.0M
Last Round: $16.0M Series AJun 2025
Rounds: 1

About

Aortyx is a Barcelona-based medtech company founded in 2018 by researchers from IQS School of Engineering and clinicians from Hospital Clínic de Barcelona to address aortic dissection. The company has developed a biomimetic, bioresorbable endovascular patch delivered through a proprietary dual-steerable catheter system that seals the aortic tear while respecting the vessel's natural dynamics. Since 2018, Aortyx has raised €16.8M in private equity plus €4.2M in competitive public grants, including a €13.8M Series A round in 2025 led by Ship2B Ventures and Clave Capital.

Summary

AORTYX is a Biotech company based in Barcelona, founded in 2018. It has raised $16.0M in total across 1 round, most recently a $16.0M Series A round in Jun 2025. Investors include Ship2B, Clave Capital and European Innovation Council Fund.